These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 22710176)

  • 61. Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.
    Malek R; Wang H; Taparra K; Tran PT
    Cells Tissues Organs; 2017; 203(2):114-127. PubMed ID: 28214899
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multivariate relationships among nucleus and Golgi properties during fibrillar migration are robust to and unchanged by epithelial-to-mesenchymal transition.
    Luo CY; Natividad RJ; Lalli ML; Asthagiri AR
    PLoS One; 2020; 15(9):e0239188. PubMed ID: 32946467
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CUTL1: a key mediator of TGFbeta-induced tumor invasion.
    Michl P; Downward J
    Cell Cycle; 2006 Jan; 5(2):132-4. PubMed ID: 16357536
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transforming growth factor β as regulator of cancer stemness and metastasis.
    Bellomo C; Caja L; Moustakas A
    Br J Cancer; 2016 Sep; 115(7):761-9. PubMed ID: 27537386
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blebbing as a physical force in cancer EMT - parallels with mitosis.
    Sekyrova P; Östblom J; Andäng M
    Semin Cancer Biol; 2012 Oct; 22(5-6):369-73. PubMed ID: 22659342
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion.
    Di Domenico M; Giordano A
    Oncotarget; 2017 May; 8(22):36869-36884. PubMed ID: 28415812
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs.
    Janakiraman H; House RP; Gangaraju VK; Diehl JA; Howe PH; Palanisamy V
    Mol Cancer Res; 2018 Apr; 16(4):567-579. PubMed ID: 29555893
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting TGFβ signal transduction for cancer therapy.
    Liu S; Ren J; Ten Dijke P
    Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EMT and inflammation: inseparable actors of cancer progression.
    Suarez-Carmona M; Lesage J; Cataldo D; Gilles C
    Mol Oncol; 2017 Jul; 11(7):805-823. PubMed ID: 28599100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A New Switch for TGFβ in Cancer.
    Yeh HW; Lee SS; Chang CY; Lang YD; Jou YS
    Cancer Res; 2019 Aug; 79(15):3797-3805. PubMed ID: 31300476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Integration of transcriptional signals at the tumor cell invasive front.
    Meulmeester E; ten Dijke P
    Cell Cycle; 2010 Jul; 9(13):2499-500. PubMed ID: 20647778
    [No Abstract]   [Full Text] [Related]  

  • 72. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition.
    Aparicio LA; Abella V; Valladares M; Figueroa A
    Cell Mol Life Sci; 2013 Dec; 70(23):4463-77. PubMed ID: 23715860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TGFβ Signaling in the Tumor Microenvironment.
    Goulet CR; Pouliot F
    Adv Exp Med Biol; 2021; 1270():89-105. PubMed ID: 33123995
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The EMT spectrum and therapeutic opportunities.
    Voon DC; Huang RY; Jackson RA; Thiery JP
    Mol Oncol; 2017 Jul; 11(7):878-891. PubMed ID: 28544151
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TGFΒ-induced transcription in cancer.
    Cantelli G; Crosas-Molist E; Georgouli M; Sanz-Moreno V
    Semin Cancer Biol; 2017 Feb; 42():60-69. PubMed ID: 27586372
    [TBL] [Abstract][Full Text] [Related]  

  • 76. TGFbeta and cancer metastasis: an inflammation link.
    Yang L
    Cancer Metastasis Rev; 2010 Jun; 29(2):263-71. PubMed ID: 20437081
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition.
    Moustakas A; Heldin CH
    J Clin Med; 2016 Jun; 5(7):. PubMed ID: 27367735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy.
    Yang L
    Curr Mol Med; 2010 Jun; 10(4):374-80. PubMed ID: 20455854
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery.
    Sailer MH; Sarvepalli D; Brégère C; Fisch U; Guentchev M; Weller M; Guzman R; Bettler B; Ghosh A; Hutter G
    J Vis Exp; 2016 Aug; (114):. PubMed ID: 27583933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds.
    Samatov TR; Tonevitsky AG; Schumacher U
    Mol Cancer; 2013 Sep; 12(1):107. PubMed ID: 24053443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.